Results 141 to 150 of about 13,385 (164)

Multidistrict invasive <i>Candida glabrata</i> infection successfully treated with echinocandin and liposomal amphotericin B combination therapy: a case report and therapeutic perspective. [PDF]

Front Med (Lausanne)
Caracciolo M, D'Aleo F, Stagno MF, Papola C, Pellicano S, Nicolò GM, Caracciolo SA, Ripepi A, Pellicano N, Scopelliti C, Principe L, La Scala S.   +11 more
europepmc   +1 more source

Persistent Non-<i>albicans</i> Predominance, High Mortality, and Azole-Non-Susceptible <i>Candida tropicalis</i>: A 15-Year Pediatric Invasive Candidiasis Cohort in Southern Thailand. [PDF]

J Fungi (Basel)
Khantee P, Pinichkijpaisal K, Yingkajorn M, Thongseiratch T, Laoprasopwattana K.   +4 more
europepmc   +1 more source

Clinical characteristics, healthcare-associated exposures, and antifungal susceptibility patterns of Candida auris colonization and invasive infections: a retrospective observational study at a single center in Turkey. [PDF]

BMC Infect Dis
Timur D, Demir C.
europepmc   +1 more source

Resistance gene mutations and phylogenetic relationships in <i>Candidozyma auris</i> isolates from Russia. [PDF]

Front Cell Infect Microbiol
Oganesyan EG, Zhuk AS, Gusarova KV, Kovyrshin SV, Alekseevskaya ES, Orlova OE, Khostelidi SN, Kozlova OP, Liubimova AV, Taraskina AE, Vasilyeva NV.   +10 more
europepmc   +1 more source

French intensive care physicians' practices for the management of high-risk patients with invasive candidiasis: results from the multicenter INSPIRE survey. [PDF]

Ann Intensive Care
Dupont H, Mira JP, Cornet M, Girardot-Seguin S, Khatib NE, Gouhier K, Novy E.   +6 more
europepmc   +1 more source

Echinocandin Resistance in Candida Species Isolates from Liver Transplant Recipients.

Antimicrobial Agents and Chemotherapy, 2017
International audienceABSTRACT Liver transplant recipients are at risk of invasive fungal infections, especially candidiasis. Echinocandin is recommended as prophylactic treatment but is increasingly associated with resistance.
Eric Dannaoui, Françoise Botterel, Jean-Marc Costa   +2 more
exaly   +2 more sources

Pan-Echinocandin Resistant C. parapsilosis Harboring an F652S Fks1 Alteration in a Patient with Prolonged Echinocandin Therapy

Journal of Fungi (Basel, Switzerland), 2022
The isolation of a pan-echinocandin-resistant Candida parapsilosis strain (anidulafungin, caspofungin, micafungin and rezafungin EUCAST MICs > 8 mg/L) from urine of a patient following prolonged exposure to echinocandins (38 days of micafungin ...
Anastasia Spiliopoulou, Maiken C Arendrup, Maria Siopi   +2 more
exaly   +1 more source

Current Perspectives on Echinocandin Class Drugs

Future Microbiology, 2011
It has been nearly a decade since caspofungin was approved for clinical use as the first echinocandin class antifungal agent, followed by micafungin and anidulafungin. The echinocandin drugs target the fungal cell wall by inhibiting the synthesis of β-1,
David S Perlin
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

isolates carrying mutations outside hotspot regions confer high echinocandin tolerance and facilitate the development of echinocandin resistance

International Journal of Antimicrobial Agents, 2023
Michael K Mansour, Geraldine Butler, Ulrike Binder   +2 more
exaly